Common Femoral Vein-to-Artery Diameter Ratio for Detection of Elevated Left Ventricular End-Diastolic Pressure: Diagnostic Accuracy Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorBurapha University

About this trial

This prospective cross-sectional diagnostic accuracy study enrolled patients undergoing coronary angiography and left heart catheterization at Burapha University Hospital, Thailand. The diameters of the common femoral vein and common femoral artery were measured using ultrasonography, and the common FVD/FAD ratio was calculated. LVEDP, measured during left heart catheterization, served as the reference standard. An elevated LVEDP (\>16 mmHg) was defined as volume overload. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

adult patients (aged ≥18 years) who were scheduled to undergo coronary angiography with left heart catheterization

Disqualifiers

(1) contraindications to cardiac catheterization; (2) inability to obtain accurate ultrasonographic measurements of the common femoral vein or common femoral artery diameters; and (3) inability to advance a guidewire across the aortic valve into the left ventricle for measurement of LVEDP.

Trial population

adult patients (aged ≥18 years) who were scheduled to undergo coronary angiography with left heart catheterization

Trial design

Design model

Other

Time perspective

Cross-sectional

Treatments tested in this trial

  • Ultrasound Measurement of Common Femoral Vein-to-Artery Diameter Ratio

    Diagnostic test

    Ultrasound measurement of the common femoral vein and common femoral artery diameters performed in the supine position. The common femoral vein-to-artery diameter ratio is calculated from the measured vessel diameters and evaluated as a diagnostic index for detecting elevated left ventricular end-diastolic pressure. The ultrasound examination is non-invasive and does not involve administration of any therapeutic intervention.

Treatment groups

105 Participants
are divided into 1 treatment group
Group A: Patients Undergoing Left Heart Catheterization1 intervention

Trial outcomes

Primary outcomes

1

Left ventricular end diastolic pressure

Left ventricular end diastolic pressure measured by left heart catheterization

Time frame
During the cardiac catheterization procedure

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.